Transmembrane pH-gradient polymersomes and their use in the scavenging of ammonia and its methylated analogs
AssigneeETH Zurich
InventorsJean-Christophe Leroux, Simon Matoori, Aaron Christoph Schmidt
Life of this patent
Estimating the term…
Loading patent…
AssigneeETH Zurich
InventorsJean-Christophe Leroux, Simon Matoori, Aaron Christoph Schmidt
Estimating the term…
The present invention provides polymersomes comprising non-biodegradable amphiphilic block-copolymers and their enteral (e.g., oral) or topical use in the treatment of an ammonia or ammonia methylated analog-associated disease or disorder or symptom thereof (e.g., hyperammonemia or trimethylaminuria). More particularly, it provides a polymersome comprising (a) a membrane, which comprises a block copolymer of poly(styrene) (PS) and poly(ethylene oxide) (PEO), wherein the PS/PEO molecular weight ratio is higher than 1.0 and lower than 4.0; and (b) a core which encloses an acid. It also provides a method of making the polymersome comprising mixing the copolymer-containing organic solvent phase with an aqueous phase containing the acid.
A polymersome comprising (a) a membrane, which comprises a dibiock copolymer of poly(styrene) (PS) and poly(ethylene oxide) (PEO), wherein the PS/PEO molecular weight ratio is from 1.3 to 3.8;
The polymersome of claim , wherein the PS/PEO molecular weight ratio is 1.3 or higher and lower than 3.1.
A method treating an ammonia or ammonia methylated analog-associated disease or disorder, or a symptom thereof, comprising a step of administering to a subject in need thereof, a composition comprising a polymersome comprising:
Dependencies are inferred from the claim text.